Cargando…

Exploring the Expression and Prognosis of Mismatch Repair Proteins and PD-L1 in Colorectal Cancer in a Chinese Cohort

PURPOSE: Exploring the expression and prognosis of mismatch repair proteins and PD-L1 in colorectal cancer. PATIENTS AND METHODS: A total of 272 patients with surgically resected CRC were enrolled in the study from January 2018 to May 2022 at Nanjing Drum Tower Hospital (The Affiliated Hospital of N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Lu, Zhang, Yaping, Li, Li, Zhang, Qun, Liu, Zhihao, Niu, Haiqing, Hu, Jing, Ding, Zhou, Shi, Xiao, Qian, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417781/ https://www.ncbi.nlm.nih.gov/pubmed/37575316 http://dx.doi.org/10.2147/CMAR.S417470

Ejemplares similares

PD-L1 Expression Is Associated with Deficient Mismatch Repair and Poor Prognosis in Middle Eastern Colorectal Cancers
por: Siraj, Abdul K., et al.
Publicado: (2021)

Mismatch repair-deficient status associates with favorable prognosis of Eastern Chinese population with sporadic colorectal cancer
por: Gong, Qing, et al.
Publicado: (2018)

Intraindividual Tumor Heterogeneity of Mismatch Repair Status in Metastatic Colorectal Cancer
por: Huang, Qianpeng, et al.
Publicado: (2023)

PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer
por: Liu, Ding-Xin, et al.
Publicado: (2020)

Low prevalence of mismatch repair deficiency in Chinese colorectal cancers: a multicenter study
por: Jiang, Wu, et al.
Publicado: (2020)

Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer
por: Jin, Hei-Ying, et al.
Publicado: (2008)

DNA mismatch repair in the context of chromatin
por: Huang, Yaping, et al.
Publicado: (2020)

Case report: A colorectal cancer patient with microsatellite instability-high and MSH2 germline mutation failed to respond to anti-PD-1 immunotherapy
por: Zhang, Qun, et al.
Publicado: (2022)

Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer
por: He, Yinjun, et al.
Publicado: (2023)

SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer
por: Zhang, Yaping, et al.
Publicado: (2023)

Correction to: DNA mismatch repair in the context of chromatin
por: Huang, Yaping, et al.
Publicado: (2020)

Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancer
por: Liu, Shousheng, et al.
Publicado: (2019)

Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer
por: Ryan, É. J., et al.
Publicado: (2018)

Mismatch repair status and high expression of PD-L1 in nasopharyngeal carcinoma
por: Zhao, Liang, et al.
Publicado: (2019)

Prognostic Value of Mismatch Repair Genes for Patients With Colorectal Cancer: Meta-Analysis
por: Hou, Jiang-tao, et al.
Publicado: (2018)

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
por: Zhao, Pengfei, et al.
Publicado: (2019)

Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer
por: Wang, Yu, et al.
Publicado: (2016)

Heterogenous mismatch-repair status in colorectal cancer
por: Joost, Patrick, et al.
Publicado: (2014)

The correlation between DNA mismatch repair status and the clinicopathological and molecular features of Chinese sporadic colorectal cancer
por: Li, Cong, et al.
Publicado: (2020)

The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance
por: Feng, Yang-chun, et al.
Publicado: (2018)

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
por: Svensson, Maria C., et al.
Publicado: (2019)

Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer
por: Sui, Qiaoqi, et al.
Publicado: (2021)

Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
por: Zhang, Cong-Min, et al.
Publicado: (2016)

Impact of age and mismatch repair status on survival in colorectal cancer
por: Li, Pan, et al.
Publicado: (2017)

Impact of mismatch-repair deficiency on the colorectal cancer immune microenvironment
por: Zhang, Yingyi, et al.
Publicado: (2017)

The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
por: Wang, Qiao-Xuan, et al.
Publicado: (2021)

Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study
por: Ma, Yu-Ting, et al.
Publicado: (2023)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

Clinical significance of mismatch repair gene expression in sporadic colorectal cancer
por: SUN, ZHENQIANG, et al.
Publicado: (2014)

Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status
por: Kong, Pengfei, et al.
Publicado: (2019)

Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patients
por: Hu, Li, et al.
Publicado: (2022)

PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma
por: Chen, Longyun, et al.
Publicado: (2021)

Prevalence and spectrum of DNA mismatch repair gene variation in the general Chinese population
por: Zhang, Li, et al.
Publicado: (2022)

Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
por: Li, Weihua, et al.
Publicado: (2020)

Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review
por: Mei, Wei-Jian, et al.
Publicado: (2022)

Minisatellite instability is found in colorectal tumours with mismatch repair deficiency
por: Coleman, M G, et al.
Publicado: (2001)

Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens
por: Grillo, F., et al.
Publicado: (2023)

The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis
por: Guan, Wen-Long, et al.
Publicado: (2021)

Evaluation of Concordance Between Deficient Mismatch Repair and Microsatellite Instability Testing and Their Association with Clinicopathological Features in Colorectal Cancer
por: Bai, Huili, et al.
Publicado: (2020)

Role of mismatch repair in aging
por: Wen, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j8691mm3o3cjtnfuq7spnv5kkd